Recurrent Salivary Gland Carcinoma

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB00002	Cetuximab	1	Completed	1
DB00530	Erlotinib	1	Active Not Recruiting	1
DB00480	Lenalidomide	1	Completed	1
DB09037	Pembrolizumab	1	Active Not Recruiting	1
DB09037	Pembrolizumab	1 / 2	Completed	1
DB02546	Vorinostat	1 / 2	Completed	1
DB04849	Cediranib	2	Completed	1
DB00002	Cetuximab	2	Completed	1
DB12941	Darolutamide	2	Recruiting	1
DB01254	Dasatinib	2	Completed	1
DB01248	Docetaxel	2	Recruiting	1
DB06186	Ipilimumab	2	Active Not Recruiting	1
DB00007	Leuprolide	2	Recruiting	1
DB00281	Lidocaine	2	Recruiting	1
DB06132	Nivolumab	2	Active Not Recruiting	1
DB09035	Nivolumab	2	Active Not Recruiting	1
DB09037	Pembrolizumab	2	Recruiting	1
DB00642	Pemetrexed	2	Recruiting	1
DB06287	Temsirolimus	2	Completed	1
DB00072	Trastuzumab	2	Recruiting	1
DB05773	Trastuzumab emtansine	2	Recruiting	1
DB02546	Vorinostat	2	Completed	1
DB00112	Bevacizumab	3	Active Not Recruiting	1
DB00958	Carboplatin	3	Active Not Recruiting	1
DB14547	Chloride ion	3	Active Not Recruiting	1
DB00515	Cisplatin	3	Active Not Recruiting	1
DB01248	Docetaxel	3	Active Not Recruiting	1
DB00544	Fluorouracil	3	Active Not Recruiting	1
DB12257	Platinum	3	Active Not Recruiting	1